VALENCIA, Calif., Nov. 5 /PRNewswire-FirstCall/ -- MannKind Corporation will release its 2007 third quarter financial results on Wednesday, November 7, 2007 at 6:00 a.m. ET.
Management of the Company will host a conference call to discuss the third quarter financial results, clinical progress and other Company developments at 8:00 a.m. ET on Wednesday, November 7, 2007. Presenting from the Company will be its Chairman and Chief Executive Officer, Alfred Mann; President and Chief Operating Officer, Hakan Edstrom; Corporate Vice President and Chief Financial Officer, Dick Anderson and Corporate Vice President and Chief Scientific Officer, Peter Richardson.
To participate in the live call by telephone, please dial (888) 566-5775 or (210) 234-0001. Those interested in listening to the conference call live via the Internet may do so by visiting the Company’s website at www.mannkindcorp.com.
A telephone replay of the call will be accessible for approximately fourteen days following completion of the call by dialing (800) 262-4859 or (203) 369-3220 and entering conference number 2363293. A replay will also be available on MannKind’s website for fourteen days.
About MannKind Corporation
MannKind Corporation focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes and cancer. Its lead product, the Technosphere(R) Insulin System, is currently in phase 3 clinical trials in the United States, Europe and Latin America to study its safety and efficacy in the treatment of diabetes. For more information on MannKind Corporation and its technology, visit http://www.mannkindcorp.com.
CONTACT: Dick Anderson, MannKind Corporation, Chief Financial Officer,
+1-661-775-5302, or danderson@mannkindcorp.com
Web site: http://www.mannkindcorp.com/
